Literature DB >> 15039532

Mutational analysis of the R33-encoded G protein-coupled receptor of rat cytomegalovirus: identification of amino acid residues critical for cellular localization and ligand-independent signalling.

Yvonne K Gruijthuijsen1, Erik V H Beuken1, Martine J Smit2, Rob Leurs2, Cathrien A Bruggeman1, Cornelis Vink1.   

Abstract

The rat cytomegalovirus (RCMV) R33 gene encodes a G protein-coupled receptor (GPCR), pR33, which possesses agonist-independent, constitutive signalling activity. To characterize this activity further, we generated a series of point and deletion mutants of pR33. Both expression of and signalling by the mutants was evaluated. Several point mutants were generated that contained modifications in the NRY motif. This motif, at aa 130-132 of pR33, is the counterpart of the common DRY motif of GPCRs, which is known to be involved in G protein coupling. We found that mutation of the asparagine residue within the NRY motif of pR33 (N(130)) to aspartic acid resulted in a mutant (N(130)D) with similar signalling characteristics to the wild-type (WT) protein, indicating that N(130) is not the determinant of constitutive activity of pR33. Interestingly, a mutant carrying an alanine at aa 130 (N(130)A) was severely impaired in G(q/11)-mediated, constitutive activation of phospholipase C, whereas it displayed similar levels of activity to pR33 in G(i/0)-mediated signalling. Another protein that contained a modified NRY motif, R(131)A, did not show constitutive activity, whereas mutants Y(132)F and Y(132)A displayed similar activities to the WT receptor. This indicated that residue R(131) is critical for pR33 function in vitro, whereas Y(132) is not. Finally, we identified two consecutive arginines within the C-terminal tails of both pR33 and its homologue from human CMV, pUL33, which are important for correct cell-surface expression of these receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039532     DOI: 10.1099/vir.0.19709-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  Common structural requirements for heptahelical domain function in class A and class C G protein-coupled receptors.

Authors:  Virginie Binet; Béatrice Duthey; Jennifer Lecaillon; Claire Vol; Julie Quoyer; Gilles Labesse; Jean-Philippe Pin; Laurent Prézeau
Journal:  J Biol Chem       Date:  2007-02-19       Impact factor: 5.157

2.  G protein-coupled receptor (GPCR) kinase 2 regulates agonist-independent Gq/11 signaling from the mouse cytomegalovirus GPCR M33.

Authors:  Joseph D Sherrill; William E Miller
Journal:  J Biol Chem       Date:  2006-11-06       Impact factor: 5.157

3.  Activation of intracellular signaling pathways by the murine cytomegalovirus G protein-coupled receptor M33 occurs via PLC-{beta}/PKC-dependent and -independent mechanisms.

Authors:  Joseph D Sherrill; Melissa P Stropes; Olivia D Schneider; Diana E Koch; Fabiola M Bittencourt; Jeanette L C Miller; William E Miller
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

4.  Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo.

Authors:  Ruth Case; Emma Sharp; Tau Benned-Jensen; Mette M Rosenkilde; Nicholas Davis-Poynter; Helen E Farrell
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

5.  Structural Diversity in Conserved Regions Like the DRY-Motif among Viral 7TM Receptors-A Consequence of Evolutionary Pressure?

Authors:  Ann-Sofie Mølleskov Jensen; Alexander Hovard Sparre-Ulrich; Nicholas Davis-Poynter; Mette Marie Rosenkilde
Journal:  Adv Virol       Date:  2012-07-30

6.  Roles of GP33, a guinea pig cytomegalovirus-encoded G protein-coupled receptor homolog, in cellular signaling, viral growth and inflammation in vitro and in vivo.

Authors:  Miei Takeda; Shinji Watanabe; Harutaka Katano; Kazuma Noguchi; Yuko Sato; Sayaka Kojima; Takuya Miura; Ryuichi Majima; Souichi Yamada; Naoki Inoue
Journal:  PLoS Pathog       Date:  2018-12-20       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.